R46L polymorphism in the PCSK9 gene: Relationship to lipid levels, subclinical vascular disease, and erectile dysfunction-Reference-Cited by-同舟云学术

R46L polymorphism in the PCSK9 gene: Relationship to lipid levels, subclinical vascular disease, and erectile dysfunction

Published:2018-07 Issue:4 Volume:12 Page:1039-1046.e3
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Mostaza Jose M.,Lahoz Carlos,Salinero-Fort Miguel A.,de Dios Olaya,Castillo Elisa,González-Alegre Teresa,García-Iglesias Francisca,Estirado Eva,Laguna Fernando,Sabín Concesa,López Silvia,Cornejo Victor,de Burgos Carmen,Sanchez Vanesa,Garcés Carmen,Puntero Belen Fernandez,Montesano Luis,Aguilera Linde Pedro PatronConcepción,Fernandez-Garcia Pedro J.,Linde Concepción Aguilera,Aguirre De Carcer Escolano Álvaro R.,Sacristán Patricio Alonso.,Álvarez Otero M. Jesús,Arribas Pérez Paloma,Asensio Ruiz Maria Luisa.,Astorga Díaz Pablo,Berriatua Ena Begoña,Bezos Varela Ana Isabel,Calatrava Triguero María José,García Carlos Casanova,Llorente Ángeles Conde,Diaz Laso Concepción,García Emilia Elviro,Dueñas Orlando Enríquez,Ferrer Zapata María Isabel,Antuña Froilán,García Lazaro Maria Isabel,Gómez Rodríguez Maria Teresa,Lucena África Gómez,Hernández Francisco Herrero,Viñals Rosa Julián,Ruiz Ogarrio Gerardo López,Manzano Maria Del Carmen Lumbreras,López Sonsoles Paloma Luquero,Cabrera Peláez Ana Martinez,Candenas Montserrat Nieto,Carrera María Alejandra Rabanal,Rodríguez Ángel Castellanos,Castellanos Ana López,García Milagros Velazquez,Pacheco Margarita Ruiz

Funder

Novo Nordisk

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference26 articles.

1. Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering;Norata;Cardiovasc Res,2016

2. Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population;Polisecki;Atherosclerosis,2008

3. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease;Cohen;N Engl J Med,2006

4. PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses;Benn;J Am Coll Cardiol,2010

5. Effects of PCSK9 genetic variants on plasma LDL cholesterol levels and risk of premature myocardial infarction in the Italian population;Guella;J Lipid Res,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of the PCSK9 R46L genetic variant on plasma insulin and glucose levels, risk of diabetes mellitus and cardiovascular disease: A meta-analysis;Nutrition, Metabolism and Cardiovascular Diseases;2024-06

2. Genetic association of lipid-lowering drug target genes with erectile dysfunction and male reproductive health;Frontiers in Endocrinology;2024-02-08

3. Correlations of PCSK9 and LDLR Gene Polymorphisms and Serum PCSK9 Levels With Atherosclerosis and Lipid Metabolism in Patients on Maintenance Hemodialysis;The Journal of Clinical Pharmacology;2023-10-02

4. Increased Carotid Intima-Media Thickness in Asymptomatic Individuals Is Associated with the PCSK9 (rs2149041) Gene Polymorphism in the Mexican Mestizo Population: Results of the GEA Cohort;Life;2022-09-30

5. A possible protective effect of the plasma PCSK9 against myocardial hypertrophy and diastolic dysfunction;Acta Poloniae Pharmaceutica - Drug Research;2022-08-24